Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Current Deferred Tax Assets (2010 - 2016)

Utah Medical Products' quarterly Current Deferred Tax Assets came in at $393000.0 in Q4 2016, up 8.26% year-on-year from $363000.0 in Q1 2016, and up 8.26% quarter-over-quarter from $363000.0 in Q4 2015.

Utah Medical Products has reported Current Deferred Tax Assets for 7 years, with the latest figure at $393000.0 in Q4 2016.

  • For the quarter ending Q4 2016, Current Deferred Tax Assets rose 8.26% year-over-year to $393000.0; the trailing twelve-month figure through Dec 2016 stood at $393000.0 (up 8.26% YoY), and the FY2016 full-year result was $393000.0, up 8.26% from the prior year.
  • Current Deferred Tax Assets for Q4 2016 stood at $393000.0, up from $363000.0 in the prior quarter.
  • The five-year high for Current Deferred Tax Assets was $451000.0 in Q4 2012, with the low at $303000.0 in Q4 2014.
  • Average Current Deferred Tax Assets over 5 years is $367600.0, with a median of $363000.0 recorded in 2015.
  • Year-over-year, Current Deferred Tax Assets jumped 35.44% in 2012 and retreated 27.27% in 2013.
  • Tracing UTMD's Current Deferred Tax Assets over 5 years: stood at $451000.0 in 2012, then dropped by 27.27% to $328000.0 in 2013, then fell by 7.62% to $303000.0 in 2014, then grew by 19.8% to $363000.0 in 2015, then gained by 8.26% to $393000.0 in 2016.
  • The last three Current Deferred Tax Assets figures came in at $393000.0 (Q4 2016), $363000.0 (Q4 2015), and $303000.0 (Q4 2014), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Utah Medical Products 204.80 Mn 117.39 Mn 5.28 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2016 393,000.00
Dec 31, 2016 393,000.00
Dec 31, 2015 363,000.00
Dec 31, 2015 363,000.00
Dec 31, 2014 303,000.00
Dec 31, 2014 303,000.00
Dec 31, 2013 328,000.00
Dec 31, 2013 328,000.00
Dec 31, 2012 451,000.00
Dec 31, 2012 451,000.00
Dec 31, 2011 333,000.00
Dec 31, 2011 333,000.00
Dec 31, 2010 185,000.00
Dec 31, 2010 185,000.00